New England Journal of Medicine· 2017Q1

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

K.C. Allen Chan, John K. S. Woo, Ann D. King, Benny Zee et al.

782citations
Q1SCImago
2017year

Short summary

Plasma Epstein-Barr virus (EBV) DNA screening detected early-stage nasopharyngeal carcinoma (NPC) in asymptomatic individuals with 97.1% sensitivity and 98.6% specificity, leading to significantly better 3-year progression-free survival (97% vs. 70%) compared to a historical cohort.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Otorhinolaryngology

OtorhinolaryngologyMedicine